Literature DB >> 728472

Interaction of anthelmintic benzimidazoles and benzimidazole derivatives with bovine brain tubulin.

P A Friedman, E G Platzer.   

Abstract

The binding and inhibitory properties of 11 benzimidazoles for bovine brain tubulin were investigated. The effects of the benzimidazoles on the initial rates of microtubule polymerization were determined by a turbidimetric assay. The median inhibitory concentrations (I50) for nocodazole, oxibendazole, parbendazole, mebendazole and fenbendazole ranged from 1.97 . 10(-6) to 6.32 . 10(-6) M. Benomyl, cambendazole and carbendazim had I50 values from 5.83 . 10(-5) to 9.01 .10(-5) M. Thiabendazole had an I50 value of 5.49 . 10(-4) M. Inhibitor constants (Ki) were determined by the colchicine binding assay. Oxibendazole, fenbendazole, and cambendazole had Ki values of 3.20 . 10(-5), 1.73 . 10(-5) and 1.10 . 10(-4) M, respectively. Oxibendazole and fenbendazole were competitive inhibitors of colchicine. In contrast, cambendazole was a noncompetitive inhibitor of colchicine. The ability of these benzimidazoles to inhibit microtubule polymerization and the mode of action for the anthelmintic benzimidazoles is discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 728472     DOI: 10.1016/0304-4165(78)90334-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  28 in total

1.  Characterization of the colchicine binding site on avian tubulin isotype betaVI.

Authors:  Shubhada Sharma; Barbara Poliks; Colby Chiauzzi; Rudravajhala Ravindra; Adam R Blanden; Susan Bane
Journal:  Biochemistry       Date:  2010-04-06       Impact factor: 3.162

2.  Nanomolar concentrations of nocodazole alter microtubule dynamic instability in vivo and in vitro.

Authors:  R J Vasquez; B Howell; A M Yvon; P Wadsworth; L Cassimeris
Journal:  Mol Biol Cell       Date:  1997-06       Impact factor: 4.138

3.  In vitro effects of flubendazole on Echinococcus granulosus protoscoleces.

Authors:  M Elissondo; M Dopchiz; L Ceballos; L Alvarez; S Sánchez Bruni; C Lanusse; G Denegri
Journal:  Parasitol Res       Date:  2005-12-22       Impact factor: 2.289

4.  In vitro and in vivo effects of flubendazole on Echinococcus granulosus metacestodes.

Authors:  M Elissondo; L Ceballos; M Dopchiz; V Andresiuk; L Alvarez; S Sánchez Bruni; C Lanusse; G Denegri
Journal:  Parasitol Res       Date:  2006-12-15       Impact factor: 2.289

5.  Fine-structure alterations in female Brugia malayi and Litomosoides carinii after in vivo treatment with flubendazole.

Authors:  M Franz; H Zahner; P Benten
Journal:  Parasitol Res       Date:  1990       Impact factor: 2.289

6.  Antihelminthic benzimidazoles are novel HIF activators that prevent oxidative neuronal death via binding to tubulin.

Authors:  Hossein Aleyasin; Saravanan S Karuppagounder; Amit Kumar; Sama Sleiman; Manuela Basso; Thong Ma; Ambreena Siddiq; Shankar J Chinta; Camille Brochier; Brett Langley; Renee Haskew-Layton; Susan L Bane; Gregory J Riggins; Irina Gazaryan; Anatoly A Starkov; Julie K Andersen; Rajiv R Ratan
Journal:  Antioxid Redox Signal       Date:  2015-01-10       Impact factor: 8.401

7.  Sub-chronic toxicity of methyl benzimidazole carbamate in rats.

Authors:  A Janardhan; A B Rao; P Sisodia
Journal:  Bull Environ Contam Toxicol       Date:  1987-05       Impact factor: 2.151

8.  Meiosis-specific failure of cell cycle progression in fission yeast by mutation of a conserved beta-tubulin residue.

Authors:  Janet L Paluh; Alison N Killilea; H William Detrich; Kenneth H Downing
Journal:  Mol Biol Cell       Date:  2003-12-02       Impact factor: 4.138

9.  Screening for microtubule-disrupting antifungal agents by using a mitotic-arrest mutant of Aspergillus nidulans and novel action of phenylalanine derivatives accompanying tubulin loss.

Authors:  Tetsuo Kiso; Ken-Ichi Fujita; Xu Ping; Toshio Tanaka; Makoto Taniguchi
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

10.  Fasciola hepatica: tegumental surface changes in adult and juvenile flukes following treatment in vitro with the sulphoxide metabolite of triclabendazole (Fasinex).

Authors:  A W Stitt; I Fairweather
Journal:  Parasitol Res       Date:  1993       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.